|
Author: V. V. McLaughlin, MD; V. F. Tapson, MD; M. D. McGoon, MD
Date Published: August-2010
Source: Medscape
Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary vascular resistance due to remodeling and occlusion of the pulmonary arterioles. Although the prevalence estimate is low, this disease has substantial effects. Over the past 2 decades, significant advances have been made in the understanding and treatment of PAH. Join our panel of experts, Drs. McLaughlin, McGoon, and Tapson, as they discuss proper diagnosis and therapeutic management of PAH.
|
For Physicians 
